Sona Nanotech Inc C.SONA

Alternate Symbol(s): SNANF

Technology Scientific & Technical Instruments

Sona Nanotech Inc. is a nanotechnology life sciences company that has developed multiple methods for the manufacturing of various types of gold nanoparticles. The Company is engaged in the research and development of its technology for use in multiplex diagnostic testing platforms and biomedical applications. Its gold nanotechnologies are adapted for use in applications, as a safe and delivery system for multiple medical treatments, for the approval of various regulatory boards, including Health Canada and the Food and Drug administration (FDA). Its gold nanorod particles are manufactured without the use of CTAB (cetyltrimethylammonium), eliminating the toxicity risks associated with the use of other gold nanorod technologies in medical applications. The Company leverages its core proprietary gold nanorod (GNR) manufacturing technology and laboratory assets to focus on the development of diagnostic tests and biologic reagents, and the advancement of its GNR intellectual property.

CSE:SONA - Post by User

Sona Nanotech Inc > Calls for FDA to speed up approval for at-home testing

<< Previous

Bullboard Posts

Next >>

Comment by Moemoney42on Aug 13, 2020 10:46am

137 Views

Post# 31403077

RE:RE:RE:RE:RE:RE:Calls for FDA to speed up approval for at-home testing

I agree whatdoiknow... with 20 years of nanotech behind us, and 600 and counting, products already in the market, this will be a wide general based event. Nice to see your common sense approach as usual..

whatdoiknow123 wrote:
I would not be too sure. Better not to get your hopes up,only to be disappointed later. I think that this a general look at the Nanotechnology Industry, albeit at a very interesting time, rather than Covid-19 orientated. SONA or their test will almost certainly not be mentioned although they will be aware of developments.
What I think will be interesting is the relevance of what is said in general about the potential of Nanotechnology from which we will be able to guage the possibilities and scale of SONA´S future development and the therapeutic areas into which they and their products will go.

SPELLING ERRORS CORRECTED